ArticleScientific reports2025
Contrastive learning uncovers cellular interactions and morphologies in the tumor microenvironment of lung adenocarcinoma linked to immunotherapy response.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung adenocarcinoma (LUAD) presents diverse histomorphological features within the tumor microenvironment (TME) that influence prognosis and response to immunotherapy. Leveraging contrastive learning, we developed an unbiased atlas of cell neighborhoods to systematically explore the LUAD microenvironment at the cellular scale and investigate how these neighborhoods combine to form histologic patterns. This multiscale approach enables a comprehensive understanding of both cell-specific interactions and broader histologic architecture in LUAD. Our analysis identified distinct histomorphological phenotype clusters of cellular neighborhoods (cn-HPCs) with prognostic significance. For example, cn-HPC 0 was associated with immune activation and favorable survival, while cn-HPC 23 was enriched in necrotic, immune-excluded regions and aligned with poorer outcomes. Through associations with immunophenotypes, co-expressed gene modules, and pathway enrichment, we found that cn-HPCs reflect underlying processes of immune modulation, cellular growth, and inflammation, offering insights into the functional landscape of LUAD. In an independent LUAD immunotherapy cohort, we found that cn-HPC 23 showed promising predictive value for treatment response. These findings suggest that fine-grained spatial profiling of the TME may offer complementary value for identifying patients more likely to benefit from immunotherapy. Taken together, our study highlights the potential of cn-HPCs to bridge histopathological patterns and clinical outcomes, supporting their relevance for prognosis and treatment stratification in LUAD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.